Academia
One month after three patients who developed adverse reactions following injections of an unauthorized herpes vaccine filed a lawsuit against Rational Vaccines, the U.S. Food and Drug Administration has launched a criminal investigation into the matter.
Pfizer joined the TriNetX global health research network, which will allow it to access clinical data from the network’s healthcare organizations.
After winning Amgen’s coveted 2017 Golden Ticket in December 2017 startup company QurAlis officially launched with financial backing from Amgen Ventures with a mission to develop a cure for Amyotrophic Lateral Sclerosis (ALS).
California-based EnCorps is a program that was developed to address declining student achievement in STEM (science, technology, engineering and math) curriculum.The program looks to bolster STEM teaching.
Beijing’s Tsinghua University will invest $276M in a JV to build a new biohub in the UK’s Cambridge Science Park.
Nebula Genomic plans to offer inexpensive genetic testing, but allow the consumer to own their own genetic data.
Jing Medicine Technology will collaborate with ShanghaiTech University in a $100M partnership to discover and develop novel small molecule cancer drugs.
The researchers took blood samples from 1,005 people with one of the eight different cancer types.
Five researchers were touted for their work in life sciences.
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
PRESS RELEASES